Your browser doesn't support javascript.
loading
A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma.
Kim, Sung Kwon; Park, Ji Eun; Kim, Kyung Hwan; Cho, Jin Mo; Moon, Jangsup; Yoon, Wan Soo; Kim, Se Hoon; Kim, Young Il; Kim, Young Zoon; Kim, Ho Sung; Dho, Yun Sik; Park, Jae Sung; Yoon, Hong In; Seo, Youngbeom; Sung, Kyoung Su; Song, Jin Ho; Wee, Chan Woo; Lee, Se Hoon; Lim, Do Hoon; Im, Jung Ho; Chang, Jong Hee; Han, Myung Hoon; Hong, Je Beom; Hwang, Kihwan; Park, Chul Kee; Lee, Youn Soo; Gwak, Ho Shin.
Afiliação
  • Kim SK; Department of Neurosurgery, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, Korea.
  • Park JE; Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim KH; Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
  • Cho JM; Department of Neurosurgery, International St. Mary's Hospital, Catholic Kwandong University, Incheon, Korea.
  • Moon J; Department of Neurology, Rare Disease Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Yoon WS; Department of Neurosurgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.
  • Kim SH; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim YI; Department of Neurosurgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
  • Kim YZ; Division of Neurooncology and Department of Neurosurgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
  • Kim HS; Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Dho YS; Department of Neurosurgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.
  • Park JS; Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Yoon HI; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Seo Y; Department of Neurosurgery, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea.
  • Sung KS; Department of Neurosurgery, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea.
  • Song JH; Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Wee CW; Department of Radiation Oncology, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
  • Lee SH; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lim DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Im JH; Department of Radiation Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Chang JH; Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Han MH; Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  • Hong JB; Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Hwang K; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Park CK; Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. nsckpark@snu.ac.kr.
  • Lee YS; Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. lys9908@catholic.ac.kr.
  • Gwak HS; Department of Cancer Control, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. nsghs@ncc.re.kr.
Brain Tumor Res Treat ; 8(1): 20-28, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32390350
ABSTRACT

BACKGROUND:

The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted the nationwide questionnaire survey for diverse queries facing to treat patients with brain tumor. As part III of the survey, the aim of this study is to evaluate the national patterns of clinical practice for patients with brain metastasis and primary central nervous system lymphoma (PCNSL).

METHODS:

A web-based survey was sent to all members of the KSNO by email. The survey included 7 questions of brain metastasis and 5 questions of PCNSL, focused on the management strategies in specific situations. All questions were developed by consensus of the Guideline Working Group.

RESULTS:

In the survey about brain metastasis, respondents preferred surgical resection with adjuvant treatment for patients with a surgically accessible single brain metastatic lesion less than 3 cm in size without extracranial systemic lesions. However, most respondents considered radiosurgery for surgically inaccessible lesions. As the preferred treatment of multiple brain metastases according to the number of brain lesions, respondents tended to choose radiotherapy with increasing number of lesions. Radiosurgery was mostly chosen for the brain metastases of less than or equal to 4. In the survey about PCNSL, a half of respondents choose high-dose methotrexate-based polychemotherapy as the first-line induction therapy for PCNSL. The consolidation and salvage therapy showed a little variation among respondents. For PCNSL patients with cerebrospinal fluid dissemination, intrathecal chemotherapy was most preferred.

CONCLUSION:

The survey demonstrates the prevailing clinical practice patterns for patients with brain metastasis and PCNSL among members of the KSNO. This information provides a point of reference for establishing a practical guideline in the management of brain metastasis and PCNSL.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Revista: Brain Tumor Res Treat Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Revista: Brain Tumor Res Treat Ano de publicação: 2020 Tipo de documento: Article